SINGAPORE & TORONTO -- The world’s largest independent healthcare marketing agency Klick Health announced it acquired Ward6 Singapore’s operations. Through the acquisition, Klick is expanding Singapore’s largest independent life sciences agency, known for defining excellence in healthcare professional (HCP) marketing and medical communications. The move also strengthens Klick’s leadership and client portfolio in the Asia-Pacific (APAC) region and underscores the award-winning global agency’s ongoing expansion and growth.

“We are proud to welcome our newest Singaporean Klicksters to the world’s largest and most integrated independent healthcare marketing agency, not to mention the most-awarded of all healthcare agencies last year,” said Graeme Read, Klick Health Managing Director, APAC. “We’re also very excited to work with their impressive roster of pharmaceutical and consumer health clients to deliver even more expertise, passion, and value to their businesses.”

Klick Health President Ari Schaefer added, “We’ve been focused on bringing the Klick magic to more life sciences clients in Asia Pacific since expanding here over two years ago. Ward6 Singapore has deep expertise in HCP marketing in the region and we are excited they are joining us to further scale our team and answer the growing demand we’re seeing from clients.”

Ward6 CEO Stuart Black said, “We are immensely proud of the work we have accomplished during our 14 years in Singapore. We were flattered when Klick leadership approached us and are delighted that our team will continue to excel as part of Klick Health and its expanded Singapore operations. Both our organizations share a commitment to fostering outstanding work environments and advancing the life sciences sector.”

Today’s news comes just over two months after AdvertisingHealth listed Klick as the world’s most-awarded healthcare agency in 2024. Klick also kicked off 2025 announcing its acquisition of Peregrine Market Access, a leading U.S. market access strategy and value communications specialist in life sciences, boosting its presence and capabilities in the increasingly important value, access, and reimbursement segments within life sciences commercialization.